XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net loss $ (100,769) $ (37,653)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 874 362
Provision for doubtful accounts 3,349  
Provision for inventory obsolescence and write-downs 917 261
Loss on disposal of fixed asset 39  
Gain on extinguishment of debt (2,194)  
Change in fair value of warrant liability 28,812 20,835
Change in fair value of earnout liability 4,183  
Change in fair value of derivative liability 5,341  
Stock-based compensation 2,538 275
Amortization of debt discount 6,670 1,789
Non-cash impact of operating lease right-of-use asset 991 1,254
Issuance of common stock warrants for services performed 433  
Other non-cash expenses   165
Changes in operating assets and liabilities:    
Accounts receivable (8,399) (3,016)
Inventories (9,795) (2,017)
Prepaid expenses and other assets (6,380) (1,621)
Accounts payable 3,578 1,442
Accrued expenses and other liabilities 4,005 1,698
Net cash used in operating activities (65,807) (16,226)
Cash flows from investing activities    
Purchase of property and equipment (3,244) (2,013)
Proceeds from disposal of property and equipment 55  
Net cash used in investing activities (3,189) (2,013)
Cash flows from financing activities    
Proceeds from convertible notes payable, net of issuance costs paid 95,000 9,679
Proceeds from Business combination and PIPE Financing, net of issuance costs paid 142,796  
Proceeds from facility borrowings 7,000 1,000
Repayments of facility borrowings (11,500)  
Proceeds as part of a redemption of convertible notes payable and Series C redeemable convertible preferred stock and warrants   3,000
Proceeds from exercise of common warrants 157  
Proceeds from issuance of Series C convertible preferred stock and preferred stock warrants   3,225
Proceeds for the exercise of Series C redeemable convertible preferred warrants 3,100 500
Payments on finance lease obligations (54) (88)
Proceeds from exercise of stock options 575 86
Net cash provided by financing activities 237,074 17,402
Net increase in cash 168,078 (837)
Cash - Beginning of year 460 1,297
Cash - End of year 168,538 460
Supplemental cash flow information    
Cash paid for interest 6,245 864
Significant noncash transactions    
Earnout liability at inception 78,960  
Warrant liability at inception 1,253  
Derivative liability at inception 17,063  
Conversion of short-term convertible notes for common stock 9,679  
Conversion of convertible notes for common stock 10,089  
Conversion of warrant liabilities for common stock 37,580  
Conversion of convertible notes payable into Series C redeemable convertible preferred stock   $ 3,000
Finance lease right-of-use asset in exchange for a lease liability $ 208